Re:Pharma companies continue to raise drug prices at rates w...
by mattkrause on Monday October 14, 2019 @04:23PM
(#21252446)
Both of your options already happen.
Basically anyone can apply to the NIH for a grant to run clinical trials. It's not easy: the funding rate for NIH grants in general is in the teens and you'll need to convince the reviews that a) the trial itself generally makes sense and b) you, specifically, can pull it off, but it can be done.
If you find a new use for an existing drug—and run a trial to prove it—the FDA will give you a period of "marketing exclusivity", wherein you will be the only one allowed to market that drug for that condition. It's not quite a patent, but it's meant to be a similar recompense/reward for doing the research.
Re:Pharma companies continue to raise drug prices at rates w...
by entee on Monday October 14, 2019 @05:01PM
(#21252852)
Yes :) I've heard of some of these mechanisms, I think they're a decent balance. All of these issues are fairly complex, it's helpful to have context.
Re:Pharma companies continue to raise drug prices at rates w...
by lojack on Monday October 14, 2019 @04:23PM
(#21252450)
Whats preventing doctors from prescribing off label?
Re:Pharma companies continue to raise drug prices at rates w...
by dekhn on Monday October 14, 2019 @05:07PM
(#21252906)
if you're in the US, doctors can do this. https://en.wikipedia.org/wiki/Off-label_use
What's preventing them? Safety, efficacy, and fear of litigation.
There are of course good arguments against, but there's at least some good arguments to allow limited patent extensions.